iPRMT1
Product Specifications
UNSPSC Description
iPRMT1 is a potent and selective PRMT1 inhibitor for breast cancer research. iPRMT1 inhibits breast cancer cell growth in vitro and in vivo with EC50 values of 90, 70, and 9 nM in MCF7, T47D, and MDA-MB-231 cells, respectively[1].
Target Antigen
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/iprmt1.html
Solubility
10 mM in DMSO
Smiles
OC(CC1)CCN1C(C=C2)=CC=C2NC3=NC(N4[C@H]5CC6=CC=CC=C46)=C(C=N3)NC5=O
Molecular Weight
428.49
References & Citations
[1]Li WJ, et al. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis. Cell Rep. 2023 Nov 7;42(11):113385.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-157151/iPRMT1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-157151/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EIA07020Bo 96 Well
Bovine secreted protein acidic and rich in cysteine (SPARC) ELISA kit
Ask
View Details